Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2447 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 48.72 USD | +1.52% | +2.85% | +3.99% | +61.70% | 910.08 M USD | ||
| 2454 |  ALMS Alumis Inc. - Common Stock | 6.97 USD | +2.95% | -1.97% | -33.30% | +54.55% | 902.16 M USD | ||
| 2459 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.58 USD | -1.76% | -9.11% | -28.99% | +10.67% | 900.43 M USD | ||
| 2462 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.15 USD | +2.76% | +2.09% | -27.17% | +40.80% | 899.90 M USD | ||
| 2474 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.32 USD | +1.47% | -9.47% | -27.73% | -8.67% | 880.43 M USD | ||
| 2489 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.21 USD | -1.92% | -8.10% | -25.80% | +45.86% | 858.87 M USD | ||
| 2513 |  SANA Sana Biotechnology, Inc. - Common Stock | 2.79 USD | +2.57% | -5.42% | -20.51% | -38.41% | 835.22 M USD | ||
| 2519 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.18 USD | -2.56% | -8.13% | -18.99% | +0.72% | 827.00 M USD | ||
| 2524 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 16.71 USD | -1.07% | -42.89% | -44.34% | -19.89% | 823.93 M USD | ||
| 2532 |  ARDX Ardelyx, Inc. - Common Stock | 3.27 USD | +0.31% | -3.25% | -12.33% | -35.25% | 814.84 M USD | ||
| 2559 |  GERN Geron Corporation - Common Stock | 1.22 USD | +1.67% | +0.83% | -18.67% | -12.23% | 783.82 M USD | ||
| 2562 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.76 USD | 0.00% | -4.86% | -20.36% | +21.38% | 783.12 M USD | ||
| 2583 |  ANNX Annexon, Inc. - common stock | 4.00 USD | -0.25% | -4.08% | -13.04% | +26.98% | 758.32 M USD | ||
| 2586 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.76 USD | -3.98% | -4.65% | -5.72% | -18.16% | 753.81 M USD | ||
| 2598 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.19 USD | -0.69% | -5.64% | -8.06% | +108.41% | 739.87 M USD | ||
| 2599 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.66 USD | -1.63% | -6.12% | -22.84% | +47.48% | 739.17 M USD | ||
| 2601 |  VSTM Verastem, Inc. - Common Stock | 8.11 USD | -1.93% | +2.01% | +1.00% | -8.88% | 734.47 M USD | ||
| 2605 |  SLDB Solid Biosciences Inc. - Common Stock | 6.82 USD | -0.44% | -6.06% | -30.19% | +19.65% | 731.28 M USD | ||
| 2606 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.36 USD | -0.87% | -11.87% | +66.08% | +27.93% | 730.91 M USD | ||
| 2617 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 13.43 USD | -1.10% | -11.41% | -31.02% | -5.75% | 720.25 M USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |